Celestia Diagnostics is developing a blood test for the accurate diagnosis of Long COVID and other infection-associated chronic conditions, addressing the current lack of reliable testing methods. This diagnostic tool aims to enhance the treatment and management of these conditions by providing measurable insights into patient health.
Funding
Funding not disclosed
Founders
Product
Problem
Millions of individuals suffer from Long COVID, a chronic condition triggered by COVID-19. The absence of reliable diagnostic tests for Long COVID hinders accurate diagnosis, effective treatment, and further research into the condition.
Solution
Celestia Diagnostics is developing a blood test designed for the accurate diagnosis of Long COVID and other infection-associated chronic conditions. This diagnostic tool aims to bridge the gap between scientific research and clinical application, providing measurable insights into patient health. By offering a reliable diagnostic method, Celestia Diagnostics seeks to improve the treatment, management, and understanding of Long COVID.
Target Audience
The primary audience includes medical professionals, researchers, and individuals seeking accurate diagnoses for Long COVID and related conditions.
Features
- Blood test for the diagnosis of Long COVID
- Diagnostic tool for other infection-associated chronic conditions